Grufity logoGrufity logo

Intuitive Surgical Inc Stock Research

ISRG

240.50USD+6.32(+2.70%)Delayed

Market Summary

USD240.50+6.32
Delayed
2.70%

ISRG Alerts

ISRG Stock Price

ISRG RSI Chart

ISRG Valuation

Market Cap

84.2B

Price/Earnings (Trailing)

63.66

Price/Sales (Trailing)

13.53

EV/EBITDA

51.4

Price/Free Cashflow

56.46

ISRG Price/Sales (Trailing)

ISRG Profitability

EBT Margin

25.82%

Return on Equity

11.98%

Return on Assets

10.19%

Free Cashflow Yield

1.77%

ISRG Fundamentals

ISRG Revenue

Revenue (TTM)

6.2B

Revenue Y/Y

6.73%

Revenue Q/Q

6.27%

ISRG Earnings

Earnings (TTM)

1.3B

Earnings Y/Y

-14.63%

Earnings Q/Q

0.28%

Price Action

52 Week Range

180.07308.97
(Low)(High)

Last 7 days

1.3%

Last 30 days

-4.5%

Last 90 days

-12.4%

Trailing 12 Months

-13.3%

ISRG Financial Health

Current Ratio

4.4

ISRG Investor Care

Buy Backs (1Y)

2.15%

Diluted EPS (TTM)

3.65

Peers (Alternatives to Intuitive Surgical)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
105.5B
30.8B
-7.09% -24.59%
25.94
3.43
-3.19% -17.38%
104.1B
18.4B
2.26% 8.00%
44.16
5.64
7.84% 18.25%
84.2B
6.2B
-4.47% -13.27%
63.66
13.53
8.97% -22.43%
67.4B
19.0B
-5.16% -6.78%
41.86
3.55
-0.43% -8.78%
49.8B
5.4B
2.41% -25.12%
32.74
9.26
2.86% 1.25%
MID-CAP
7.2T
489.7M
9.34% 31.15%
82.2K
16.8K
106.51% 2464.23%
10.2B
847.1M
-3.64% 34.52%
-5.1K
12.05
13.32% -137.89%
5.2B
1.0B
-11.64% -20.31%
30.19
5.09
6.76% 24.45%
3.5B
410.9M
4.51% -3.13%
-29.82
8.43
27.29% -14.60%
2.7B
801.2M
1.13% -58.87%
-28.25
3.34
14.00% -707.69%
SMALL-CAP
1.7B
138.6M
-15.68% 29.18%
-30.43
12.07
36.62% -10.44%
1.3B
820.0M
-8.35% -12.22%
25.89
1.59
10.13% 701.59%
853.3M
154.8M
-6.04% 0.61%
-8.2
5.51
60.29% -2309.58%
828.4M
239.8M
0.30% 1.49%
-21.88
3.45
-4.74% -31.15%

Financials for Intuitive Surgical

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue1.7%6,2226,1185,9645,9065,710
Gross Profit1.2%4,1964,1464,0654,0663,959
Operating Expenses5.1%2,6192,4912,3672,2532,138
  S&GA Expenses4.0%1,7401,6731,6001,5321,467
  R&D Expenses7.4%879818767722671
EBITDA-3.6%1,6071,6661,7252,124-
EBITDA Margin-5.2%0.26*0.27*0.34*0.36*-
Earnings Before Taxes-3.6%1,6071,6661,7251,8441,890
EBT Margin-5.2%0.26*0.27*0.34*0.31*-
Net Income-4.0%1,3221,3781,4351,6441,705
Net Income Margin-5.7%0.21*0.23*0.29*0.28*-
Free Cahsflow-8.0%1,4911,6211,7391,835-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets-2.2%12,97413,26113,70513,67813,555
  Current Assets-0.6%6,2536,2936,2935,8035,845
    Cash Equivalents2.8%1,5811,5381,5361,1031,291
  Inventory6.7%893837724653587
  Net PPE5.8%2,3742,2442,1091,9681,876
  Goodwill0.1%349348349343344
Liabilities10.4%1,8611,6871,6231,5221,604
  Current Liabilities15.3%1,4221,2331,1751,1121,150
Shareholder's Equity-4.1%11,04211,51512,08212,15711,901
  Retained Earnings-12.9%3,5004,0184,6834,8584,761
  Additional Paid-In Capital0.2%7,7047,6857,4847,3557,164
Accumulated Depreciation27.8%1,238969---
Shares Outstanding-0.9%350353357359358
Minority Interest20.6%71.0059.0059.0055.0050.00
Cashflow (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-8.0%1,4911,6211,7391,8352,089
  Share Based Compensation1.9%513503485467449
Cashflow From Investing784.4%1,371155-1,228-2,079-2,461
Cashflow From Financing-61.8%-2,572-1,590-595-54.7043.00
  Buy Backs62.3%2,6071,6076071070.00

Risks for ISRG

What is the probability of a big loss on ISRG?

68.5%


Probability that Intuitive Surgical stock will be more than 20% underwater in next one year

36.9%


Probability that Intuitive Surgical stock will be more than 30% underwater in next one year.

16.9%


Probability that Intuitive Surgical stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does ISRG drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Intuitive Surgical was unfortunately bought at previous high price.

Drawdowns

Returns for ISRG

Cumulative Returns on ISRG

16.5%


10-Year Cumulative Returns

20.0%


7-Year Cumulative Returns

10.0%


5-Year Cumulative Returns

14.3%


3-Year Cumulative Returns

What are the long-term rolling returns for ISRG?

FIve years rolling returns for Intuitive Surgical.

Annualized Returns

Which funds bought or sold ISRG recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-15
B. Riley Wealth Advisors, Inc.
reduced
-5.37
534,326
2,108,330
0.06%
2023-03-10
BAILLIE GIFFORD & CO
added
1.66
345,654,000
1,132,740,000
1.18%
2023-03-10
Financial Alternatives, Inc
new
-
315,236
315,236
0.31%
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
added
18.57
31,999,400
79,154,400
0.09%
2023-03-10
MATHER GROUP, LLC.
reduced
-12.91
55,335
295,335
0.01%
2023-03-08
Capital Asset Advisory Services LLC
added
18.33
508,674
1,234,670
0.10%
2023-03-06
NORTH STAR ASSET MANAGEMENT INC
added
10.04
1,892,380
5,283,380
0.33%
2023-03-06
Rockefeller Capital Management L.P.
added
1.32
10,519,000
34,738,000
0.17%
2023-03-03
TIAA, FSB
reduced
-3.54
174,434
651,434
-%
2023-03-02
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
new
-
2,442,550
2,442,550
0.03%

1–10 of 47

Latest Funds Activity

Are funds buying ISRG calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own ISRG
No. of Funds

Intuitive Surgical News

MarketBeat

Renaissance Investment Group LLC Acquires 475 Shares of ....

MarketBeat,
5 hours ago

Yahoo Finance

13 Best Automation Stocks To Buy Now.

Yahoo Finance,
47 hours ago

Nasdaq

The Motley Fool

The Motley Fool

Schedule 13G FIlings of Intuitive Surgical

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
price t rowe associates inc /md/
5.9%
20,823,995
SC 13G/A
Feb 09, 2023
vanguard group inc
8.33%
29,425,186
SC 13G/A
Feb 03, 2023
blackrock inc.
8.0%
28,447,145
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
6.9%
24,756,021
SC 13G/A
Feb 07, 2022
blackrock inc.
7.4%
26,538,660
SC 13G/A
Feb 16, 2021
price t rowe associates inc /md/
8.1%
9,599,898
SC 13G/A
Feb 10, 2021
vanguard group inc
7.76%
9,127,891
SC 13G/A
Feb 08, 2021
fmr llc
-
0
SC 13G/A
Jan 29, 2021
blackrock inc.
7.6%
8,888,304
SC 13G/A
Feb 14, 2020
price t rowe associates inc /md/
8.9%
10,347,449
SC 13G/A

ISRG Fair Value

Intuitive Surgical fair value in different scenarios

The table shows the Fair Value estimates for Intuitive Surgical for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

89.83

-62.65%

115.43

-52.00%

160.35

-33.33%

205.33

-14.62%

234.58

-2.46%
Current Inflation

82.50

-65.70%

104.30

-56.63%

141.86

-41.01%

179.18

-25.50%

203.67

-15.31%
Very High Inflation

73.50

-69.44%

90.90

-62.20%

120.15

-50.04%

148.97

-38.06%

168.15

-30.08%

Historical Intuitive Surgical Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Intuitive Surgical

View All Filings
Date Filed Form Type Document
Mar 10, 2023
DEF 14A
DEF 14A
Mar 10, 2023
DEFA14A
DEFA14A
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading

Latest Insider Trading transactions for ISRG

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-01
Curet Myriam
sold
-286,273
228
-1,253
evp & chief medical officer
2023-02-28
Widman Fredrik
sold (taxes)
-104,602
229
-456
vp corporate controller
2023-02-28
Curet Myriam
sold (taxes)
-344,314
229
-1,501
evp & chief medical officer
2023-02-28
GUTHART GARY S
acquired
-
-
6,371
president & ceo
2023-02-28
DeSantis Robert
acquired
-
-
3,679
evp & chief product officer
2023-02-28
MOHR MARSHALL
acquired
-
-
3,259
executive vp global business s
2023-02-28
Samath Jamie
sold (taxes)
-159,655
229
-696
chief financial officer
2023-02-28
Charlton Henry L
sold (taxes)
-170,666
229
-744
senior vice president & chief
2023-02-28
Rosa David J.
acquired
-
-
3,760
evp chief strategy & growth of
2023-02-28
Samath Jamie
acquired
-
-
2,009
chief financial officer

1–10 of 50

Gary S. Guthart
9790
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

ISRG Income Statement

2022-09-30
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue:    
Total revenue$ 1,557.4$ 1,403.3$ 4,567.2$ 4,159.4
Cost of revenue:    
Total cost of revenue505.3431.91,482.11,261.7
Gross profit1,052.1971.43,085.12,897.7
Operating expenses:    
Selling, general and administrative436.1363.31,245.61,039.5
Research and development217.1165.5634.9487.6
Total operating expenses653.2528.81,880.51,527.1
Income from operations398.9442.61,204.61,370.6
Interest and other income, net3.918.57.565.5
Income before taxes402.8461.11,212.11,436.1
Income tax expense78.173.9204.490.7
Net income324.7387.21,007.71,345.4
Less: net income attributable to noncontrolling interest in joint venture0.76.710.321.4
Net income attributable to Intuitive Surgical, Inc.$ 324.0$ 380.5$ 997.4$ 1,324.0
Net income per share attributable to Intuitive Surgical, Inc.:    
Basic (in dollars per share)$ 0.91$ 1.07$ 2.79$ 3.72
Diluted (in dollars per share)$ 0.90$ 1.04$ 2.74$ 3.63
Shares used in computing net income per share attributable to Intuitive Surgical, Inc.:    
Basic (in shares)355.3356.8357.2355.6
Diluted (in shares)360.5366.8363.7365.1
Other comprehensive loss, net of tax:    
Change in unrealized gains on hedge instruments$ 2.3$ 2.0$ 7.7$ 8.0
Change in unrealized losses on available-for-sale securities(37.3)(4.5)(161.4)(20.5)
Change in foreign currency translation losses(10.0)(2.8)(12.0)(7.9)
Change in prior service cost for employee benefit plans0.10.20.20.4
Other comprehensive loss(44.9)(5.1)(165.5)(20.0)
Total comprehensive income279.8382.1842.21,325.4
Less: comprehensive income (loss) attributable to noncontrolling interest(0.8)6.68.221.0
Total comprehensive income attributable to Intuitive Surgical, Inc.280.6375.5834.01,304.4
Corporate Joint Venture    
Operating expenses:    
Less: net income attributable to noncontrolling interest in joint venture0.76.710.321.4
Product    
Revenue:    
Total revenue1,297.51,170.63,806.33,481.2
Cost of revenue:    
Total cost of revenue421.6355.81,239.91,049.1
Service    
Revenue:    
Total revenue259.9232.7760.9678.2
Cost of revenue:    
Total cost of revenue$ 83.7$ 76.1$ 242.2$ 212.6

ISRG Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 1,538.0$ 1,290.9
Short-term investments2,775.92,913.1
Accounts receivable, net849.6782.7
Inventory837.1587.1
Prepaids and other current assets292.5271.1
Total current assets6,293.15,844.9
Property, plant, and equipment, net2,243.71,876.4
Long-term investments3,078.14,415.5
Deferred tax assets587.4441.4
Intangible and other assets, net710.3633.2
Goodwill348.2343.6
Total assets13,260.813,555.0
Current liabilities:  
Accounts payable164.2121.2
Accrued compensation and employee benefits308.2350.1
Deferred revenue358.9377.2
Other accrued liabilities402.1301.3
Total current liabilities1,233.41,149.8
Other long-term liabilities453.4453.7
Total liabilities1,686.81,603.5
Contingencies (Note 8)
Stockholders’ equity:  
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of September 30, 2022, and December 31, 20210.00.0
Common stock, 600.0 shares authorized, $0.001 par value, 353.3 shares and 357.7 shares issued and outstanding as of September 30, 2022, and December 31, 2021, respectively0.40.4
Additional paid-in capital7,684.87,164.0
Retained earnings4,017.84,760.9
Accumulated other comprehensive loss(187.6)(24.2)
Total Intuitive Surgical, Inc. stockholders’ equity11,515.411,901.1
Noncontrolling interest in joint venture58.650.4
Total stockholders’ equity11,574.011,951.5
Total liabilities and stockholders’ equity$ 13,260.8$ 13,555.0